Home > Publications Database > Towards a name change of schizophrenia: Positive and Negative Symptoms Disorder (PND). > print |
001 | 279050 | ||
005 | 20250713001356.0 | ||
024 | 7 | _ | |a 10.1007/s00406-025-02018-8 |2 doi |
024 | 7 | _ | |a pmid:40387871 |2 pmid |
024 | 7 | _ | |a 1433-8491 |2 ISSN |
024 | 7 | _ | |a 0003-9373 |2 ISSN |
024 | 7 | _ | |a altmetric:177333145 |2 altmetric |
037 | _ | _ | |a DZNE-2025-00680 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Leucht, Stefan |b 0 |
245 | _ | _ | |a Towards a name change of schizophrenia: Positive and Negative Symptoms Disorder (PND). |
260 | _ | _ | |a Darmstadt |c 2025 |b Steinkopff |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1751892069_25642 |2 PUB:(DE-HGF) |x Editorial |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a We propose renaming schizophrenia to Positive and Negative Symptoms Disorder (PND) to reduce stigma, enhance clarity, and align with current diagnostic criteria. The term reflects core symptom domains, is translatable, ICD compatible, and avoids misleading associations. If cognitive deficits should be part of the name, it would be Positive, Negative, Cognitive Symptoms disorder. Stakeholder input and linguistic evaluation are essential for successful implementation and global acceptance. |
536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Schizophrenia: classification |2 MeSH |
650 | _ | 2 | |a Schizophrenia: physiopathology |2 MeSH |
650 | _ | 2 | |a Schizophrenia: diagnosis |2 MeSH |
650 | _ | 2 | |a Terminology as Topic |2 MeSH |
650 | _ | 2 | |a Schizophrenic Psychology |2 MeSH |
650 | _ | 2 | |a Cognitive Dysfunction |2 MeSH |
700 | 1 | _ | |a Yurtseven, Deniz S |b 1 |
700 | 1 | _ | |a Priller, Josef |0 P:(DE-2719)2811122 |b 2 |u dzne |
700 | 1 | _ | |a Davis, John M |b 3 |
700 | 1 | _ | |a van Os, Jim |b 4 |
700 | 1 | _ | |a Sommer, Iris E C |b 5 |
773 | _ | _ | |a 10.1007/s00406-025-02018-8 |g Vol. 275, no. 4, p. 963 - 971 |0 PERI:(DE-600)1459045-1 |n 4 |p 963 - 971 |t European archives of psychiatry and clinical neuroscience |v 275 |y 2025 |x 0003-9373 |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/279050/files/DZNE-2025-00680.pdf |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/279050/files/DZNE-2025-00680.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:279050 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2811122 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-07 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-07 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-07 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2025-01-07 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR ARCH PSY CLIN N : 2022 |d 2025-01-07 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2025-01-07 |
915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2025-01-07 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-07 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2025-01-07 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2025-01-07 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-07 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2025-01-07 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2025-01-07 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-07 |
920 | 1 | _ | |0 I:(DE-2719)5000007 |k AG Priller |l Translational Neuropsychiatry |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)5000007 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|